Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DYRK inhibitors(DYRK kinase inhibitors), LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | - | |
Down Syndrome | Preclinical | US | - | |
Parkinson Disease | Preclinical | US | - |